CORDLIFE GROUP LIMITED (P8A) fair value: what the stock is really worth
As of Nov 10, 2026: fair value (intrinsic value) of CORDLIFE GROUP LIMITED stock S$0.11, price S$0.09, upside +17.2%, quality 47 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
CORDLIFE GROUP LIMITED
P8A · SGThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range 0.0910 SGD – 0.5550 SGD · fair‑value band 0.0821 SGD – 0.1313 SGD · the 0.0910 SGD price screens below the 0.1067 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether CORDLIFE GROUP is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Cordlife GrouCordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics.
Show moreShow less
The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples.
The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services.
The company also provides corneal lenticule banking, and lifestyle genetic screening services for adults. In addition, it offers life sprouts, medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services.
Cordlife Group Limited was incorporated in 2001 and is based in Singapore.
Stock analysis
CORDLIFE GROUP LIMITED (P8A) currently trades at 0.0910 SGD, while our estimate is 0.1067 SGD, so the stock looks roughly fairly valued today (gap 14.7%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 0.0821 SGD (bear) to 0.1313 SGD (bull), the price of 0.0910 SGD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
CORDLIFE GROUP LIMITED reported revenue of 38.9M SGD in FY2025 versus 56.7M SGD in FY2021, a compound −9.0%/yr. Reported net income was −12.6M SGD in FY2025.
Key figures
Market cap 23.3M SGD (≈ $18.1M) Micro · P/S ratio 0.64 · EPS (TTM) −0.0400 SGD · Dividend yield 0.3% · Net margin −28.9% · Return on equity −10.1% · Return on assets (EBIT) −3.3% (5-year average) · Operating margin −18.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).
What moves the price
The share trades about 52% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at 17%, P8A screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch P8A, get fair value alerts →
Compare CORDLIFE GROUP LIMITED with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Piotroski F-Score screener with fair value
- Valuation of the Singapore market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs P8A |
| IQVIA Holdings IQV | $265.12 | $291.63 | +10% | vs P8A |
| Illumina, Inc ILMN | $207.01 | $227.71 | +10% | vs P8A |
| Thermo Fisher Scientific Inc TMO | $700.22 | $686.04 | −2% | vs P8A |
| Danaher Corporation DHR | $233.02 | $209.18 | −10% | vs P8A |
| IDEXX Laboratories, Inc IDXX | $704.23 | $496.48 | −30% | vs P8A |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs P8A |
| Mettler-Toledo International Inc MTD | $1,739 | $655.06 | −62% | vs P8A |
| Agilent Technologies, Inc A | $173.96 | $64.53 | −63% | vs P8A |
| Waters Corporation WAT | $460.25 | $91.26 | −80% | vs P8A |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is CORDLIFE GROUP LIMITED (P8A) overvalued or undervalued?
What is the fair value of P8A?
What is the quality score of P8A?
What is the price target for CORDLIFE GROUP LIMITED (P8A)?
What is the CORDLIFE GROUP LIMITED stock forecast for 2026?
What is the revenue of CORDLIFE GROUP LIMITED (P8A)?
Does CORDLIFE GROUP LIMITED pay a dividend?
How much is the dividend of CORDLIFE GROUP LIMITED (P8A)?
What is the intrinsic value of CORDLIFE GROUP LIMITED (P8A)?
Is CORDLIFE GROUP LIMITED stock overvalued or undervalued in 2026?
Is fair value the same as the market price of P8A?
How much is CORDLIFE GROUP LIMITED worth?
What do the bullish and bearish scenarios say about P8A?
How solid is the balance sheet of CORDLIFE GROUP LIMITED (P8A)?
How far is P8A from its 52-week high?
Which stocks are comparable to CORDLIFE GROUP LIMITED?
Is CORDLIFE GROUP LIMITED stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of CORDLIFE GROUP LIMITED (P8A)?
What should I pay attention to with CORDLIFE GROUP LIMITED right now?
Key figures of CORDLIFE GROUP LIMITED
How large is the market capitalisation of CORDLIFE GROUP LIMITED (P8A)?
What is the P/S ratio of CORDLIFE GROUP LIMITED (P8A)?
What are the earnings per share of CORDLIFE GROUP LIMITED (P8A)?
What is the dividend yield of CORDLIFE GROUP LIMITED (P8A)?
What is the net margin of CORDLIFE GROUP LIMITED (P8A)?
What is the return on equity of CORDLIFE GROUP LIMITED (P8A)?
What is the EBIT return on assets of CORDLIFE GROUP LIMITED (P8A)?
What is the operating margin of CORDLIFE GROUP LIMITED (P8A)?
How fast is revenue growing at CORDLIFE GROUP LIMITED (P8A)?
How fast are earnings growing at CORDLIFE GROUP LIMITED (P8A)?
How much free cash flow does CORDLIFE GROUP LIMITED (P8A) generate?
Watch CORDLIFE GROUP LIMITED in the live analysis
One click puts CORDLIFE GROUP LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.